(Q38720314)

5 September 2017

title

CDK3 is a major target of miR-150 in cell proliferation and anti-cancer effect (English)

1 reference

5 September 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108217%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Liang Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108217%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Yongyong Xi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108217%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Feng Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108217%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Heng Jiang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108217%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Qiqiang He

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108217%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Dejia Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108217%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

17 January 2017

1 reference

Experimental and Molecular Pathology

5 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108217%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108217%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108217%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

181-190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108217%20AND%20SRC:MED&resulttype=core&format=json

Pharmacological therapies for muscular dystrophies

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

The functions of animal microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

MicroRNAs: genomics, biogenesis, mechanism, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

Translational regulation of utrophin by miRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

A microRNA signature predicts survival in early stage small-cell lung cancer treated with surgery and adjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

MicroRNA microarray expression profiling in human myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

miR-150 blocks MLL-AF9-associated leukemia through oncogene repression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

X chromosome-linked muscular dystrophy (mdx) in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

A parsimonious model for gene regulation by miRNAs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

Regulation of mRNA translation and stability by microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

Most mammalian mRNAs are conserved targets of microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

The Expression of c-Myb Correlates with the Levels of Rhabdomyosarcoma-specific Marker Myogenin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

A global downregulation of microRNAs occurs in human quiescent satellite cells during myogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

Resolution of skeletal muscle inflammation in mdx dystrophic mouse is accompanied by increased immunoglobulin and interferon-gamma production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

miR-150 modulates cisplatin chemosensitivity and invasiveness of muscle-invasive bladder cancer cells via targeting PDCD4 in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

The MyomiR network in skeletal muscle plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I-Transformed and ATL Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

Role of non-coding RNAs in maintaining primary airway smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

miR-126 Drives Quiescence and Self-Renewal in Leukemic Stem Cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

Cyclin C/cdk3 promotes Rb-dependent G0 exit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

Adult care for Duchenne muscular dystrophy in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

MicroRNA in myogenesis and muscle atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

The role of microRNA-150 as a tumor suppressor in malignant lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

miR-150 promotes the proliferation of lung cancer cells by targeting P53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

MiR-150-5p suppresses colorectal cancer cell migration and invasion through targeting MUC4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.008

10.1016/J.YEXMP.2017.01.008

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28108217%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference